Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
UBS
Fish and Richardson
Novartis
Express Scripts
Daiichi Sankyo
US Army
Chinese Patent Office
AstraZeneca
Deloitte

Generated: February 22, 2018

DrugPatentWatch Database Preview

ZINECARD Drug Profile

« Back to Dashboard

When do Zinecard patents expire, and what generic alternatives are available?

Zinecard is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in ZINECARD is dexrazoxane hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dexrazoxane hydrochloride profile page.
Drug patent expirations by year for ZINECARD
Pharmacology for ZINECARD
Medical Subject Heading (MeSH) Categories for ZINECARD

US Patents and Regulatory Information for ZINECARD

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ZINECARD

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Fuji
Merck
Covington
AstraZeneca
Colorcon
Queensland Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot